A biotech company can now legally bring back the dead using stem cells in their clinical trials. We can now stop asking if it’s possible to bring someone back to life; instead, the success of their trials will leave us wondering “Should we bring the dead back to life?” Read more about the company Bioquark and their research on The Mind Unleashed.
Bring Back the Dead with Mesenchymal Stem Cells
Who Are They Bringing Back to Life?
This stem cell research will involve 20 patients who are medically labeled as brain-dead. They are also legally classified as deceased. However, the participants’ deaths need to be caused by traumatic brain injuries. In addition, the participants need to be aged 15-65 but any gender. The research will attempt to bring back the dead by regrowing and stimulating their dead neurons.
What Is Bioquark?
Bioquark is a biotech company in the U.S. that specializes in the repair and regeneration of human tissues and organs. Their company aims to utilize the potential of stem cells to assist patients with innovative regenerative medicine. This includes reanimating the neurons of a deceased human brain.
When Was Their Trial Granted?
Bioquark sent in their trial application a while back, in 2016. However, the Institutional Review Board of the U.S. and India only allowed their clinical trials last year. The record of their study states that they’ll begin in July 2018 and finish in the same month.
Where Will They Conduct the Study?
The trials for this medical research will be in Rudrapur India, at Anupam Hospital. They are currently in the process of recruiting 20 participants and estimate the trial to only run on a time frame of 15 days.
Why Can Their Success be Revolutionary?
The technique they’ll be using is both unique and untested. But if their clinical trials are successful, stem cell research would be the ultimate key to bringing back deceased loved ones. Stem cells will not just be limited to regenerating damaged tissues and cells but will be able to revive whole organs.
How Will the Procedure Work?
When they have all 20 participants, they’ll be implanting mesenchymal stem cells into the patients’ brains. Additionally, Bioquark will also use nerve stimulation techniques and chemical infusions to treat the spinal cord. During the trials, the participants will be connected to support machines to keep their bodies from decomposing. Finally, they’ll be closely monitoring the brain activity of all participants.
Watch this video from InformOverload to learn more about Bioquark’s research!
After the board’s approval, Bioquark has been preparing for one of the most revolutionary stem cell research trials today. They’re testing to find out if mesenchymal stem cells are the key to reviving deceased patients due to traumatic brain injuries. The success of their clinical trials could heavily change the field of medicine and stem cell research in regenerative medicine.
What do you think of Bioquark’s research? Do you think they will be successful? Share your thoughts and experiences with us in the comments below!